- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Transdermal Drug Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Transdermal Drug Patches market size is estimated to be worth US$ 6850.7 million in 2021 and is forecast to a readjusted size of USD 8516.5 million by 2028 with a CAGR of 3.2% during review period. Rx Channel accounting for % of the Transdermal Drug Patches global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Methyl Salicylate-based Patch segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Transdermal Drug Patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, and Mylan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Transdermal Drug Patches market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others
Market segment by Application can be divided into
Rx Channel
OTC Channel
The key market players for global Transdermal Drug Patches market are listed below:
Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grünenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Dr Reddy’s Laboratories
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Transdermal Drug Patches product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Transdermal Drug Patches, with price, sales, revenue and global market share of Transdermal Drug Patches from 2019 to 2022.
Chapter 3, the Transdermal Drug Patches competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Transdermal Drug Patches breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Transdermal Drug Patches market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transdermal Drug Patches.
Chapter 13, 14, and 15, to describe Transdermal Drug Patches sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Transdermal Drug Patches Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Transdermal Drug Patches Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Methyl Salicylate-based Patch
1.2.3 Rivastigmine Transdermal Patch
1.2.4 Fentanyl Transdermal Patch
1.2.5 Lidocaine Patch
1.2.6 Diclofenac Patch
1.2.7 Nicotine Transdermal Patch
1.2.8 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Transdermal Drug Patches Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Rx Channel
1.3.3 OTC Channel
1.4 Global Transdermal Drug Patches Market Size & Forecast
1.4.1 Global Transdermal Drug Patches Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Transdermal Drug Patches Sales in Volume (2017-2028)
1.4.3 Global Transdermal Drug Patches Price (2017-2028)
1.5 Global Transdermal Drug Patches Production Capacity Analysis
1.5.1 Global Transdermal Drug Patches Total Production Capacity (2017-2028)
1.5.2 Global Transdermal Drug Patches Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Transdermal Drug Patches Market Drivers
1.6.2 Transdermal Drug Patches Market Restraints
1.6.3 Transdermal Drug Patches Trends Analysis
2 Manufacturers Profiles
2.1 Hisamitsu Pharmaceutical
2.1.1 Hisamitsu Pharmaceutical Details
2.1.2 Hisamitsu Pharmaceutical Major Business
2.1.3 Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
2.1.4 Hisamitsu Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Transdermal Drug Patches Product and Services
2.2.4 Johnson & Johnson Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Transdermal Drug Patches Product and Services
2.3.4 Novartis Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 UCB Pharma
2.4.1 UCB Pharma Details
2.4.2 UCB Pharma Major Business
2.4.3 UCB Pharma Transdermal Drug Patches Product and Services
2.4.4 UCB Pharma Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Transdermal Drug Patches Product and Services
2.5.4 Mylan Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Teva Pharmaceutical
2.6.1 Teva Pharmaceutical Details
2.6.2 Teva Pharmaceutical Major Business
2.6.3 Teva Pharmaceutical Transdermal Drug Patches Product and Services
2.6.4 Teva Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Nitto Denko
2.7.1 Nitto Denko Details
2.7.2 Nitto Denko Major Business
2.7.3 Nitto Denko Transdermal Drug Patches Product and Services
2.7.4 Nitto Denko Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Grünenthal
2.8.1 Grünenthal Details
2.8.2 Grünenthal Major Business
2.8.3 Grünenthal Transdermal Drug Patches Product and Services
2.8.4 Grünenthal Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 IBSA Group
2.9.1 IBSA Group Details
2.9.2 IBSA Group Major Business
2.9.3 IBSA Group Transdermal Drug Patches Product and Services
2.9.4 IBSA Group Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK Transdermal Drug Patches Product and Services
2.10.4 GSK Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Luye Pharma Group
2.11.1 Luye Pharma Group Details
2.11.2 Luye Pharma Group Major Business
2.11.3 Luye Pharma Group Transdermal Drug Patches Product and Services
2.11.4 Luye Pharma Group Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Pfizer
2.12.1 Pfizer Details
2.12.2 Pfizer Major Business
2.12.3 Pfizer Transdermal Drug Patches Product and Services
2.12.4 Pfizer Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Chattem
2.13.1 Chattem Details
2.13.2 Chattem Major Business
2.13.3 Chattem Transdermal Drug Patches Product and Services
2.13.4 Chattem Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Dr Reddy’s Laboratories
2.14.1 Dr Reddy’s Laboratories Details
2.14.2 Dr Reddy’s Laboratories Major Business
2.14.3 Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
2.14.4 Dr Reddy’s Laboratories Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Bayer
2.15.1 Bayer Details
2.15.2 Bayer Major Business
2.15.3 Bayer Transdermal Drug Patches Product and Services
2.15.4 Bayer Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Mundipharma
2.16.1 Mundipharma Details
2.16.2 Mundipharma Major Business
2.16.3 Mundipharma Transdermal Drug Patches Product and Services
2.16.4 Mundipharma Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Endo International
2.17.1 Endo International Details
2.17.2 Endo International Major Business
2.17.3 Endo International Transdermal Drug Patches Product and Services
2.17.4 Endo International Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Beijing Tide Pharmaceutical
2.18.1 Beijing Tide Pharmaceutical Details
2.18.2 Beijing Tide Pharmaceutical Major Business
2.18.3 Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
2.18.4 Beijing Tide Pharmaceutical Transdermal Drug Patches Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Transdermal Drug Patches Breakdown Data by Manufacturer
3.1 Global Transdermal Drug Patches Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Transdermal Drug Patches Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Transdermal Drug Patches
3.4 Market Concentration Rate
3.4.1 Top 3 Transdermal Drug Patches Manufacturer Market Share in 2021
3.4.2 Top 6 Transdermal Drug Patches Manufacturer Market Share in 2021
3.5 Global Transdermal Drug Patches Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Transdermal Drug Patches Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Transdermal Drug Patches Market Size by Region
4.1.1 Global Transdermal Drug Patches Sales in Volume by Region (2017-2028)
4.1.2 Global Transdermal Drug Patches Revenue by Region (2017-2028)
4.2 North America Transdermal Drug Patches Revenue (2017-2028)
4.3 Europe Transdermal Drug Patches Revenue (2017-2028)
4.4 Asia-Pacific Transdermal Drug Patches Revenue (2017-2028)
4.5 South America Transdermal Drug Patches Revenue (2017-2028)
4.6 Middle East and Africa Transdermal Drug Patches Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Transdermal Drug Patches Sales in Volume by Type (2017-2028)
5.2 Global Transdermal Drug Patches Revenue by Type (2017-2028)
5.3 Global Transdermal Drug Patches Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Transdermal Drug Patches Sales in Volume by Application (2017-2028)
6.2 Global Transdermal Drug Patches Revenue by Application (2017-2028)
6.3 Global Transdermal Drug Patches Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Transdermal Drug Patches Sales by Type (2017-2028)
7.2 North America Transdermal Drug Patches Sales by Application (2017-2028)
7.3 North America Transdermal Drug Patches Market Size by Country
7.3.1 North America Transdermal Drug Patches Sales in Volume by Country (2017-2028)
7.3.2 North America Transdermal Drug Patches Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Transdermal Drug Patches Sales by Type (2017-2028)
8.2 Europe Transdermal Drug Patches Sales by Application (2017-2028)
8.3 Europe Transdermal Drug Patches Market Size by Country
8.3.1 Europe Transdermal Drug Patches Sales in Volume by Country (2017-2028)
8.3.2 Europe Transdermal Drug Patches Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Transdermal Drug Patches Sales by Type (2017-2028)
9.2 Asia-Pacific Transdermal Drug Patches Sales by Application (2017-2028)
9.3 Asia-Pacific Transdermal Drug Patches Market Size by Region
9.3.1 Asia-Pacific Transdermal Drug Patches Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Transdermal Drug Patches Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Transdermal Drug Patches Sales by Type (2017-2028)
10.2 South America Transdermal Drug Patches Sales by Application (2017-2028)
10.3 South America Transdermal Drug Patches Market Size by Country
10.3.1 South America Transdermal Drug Patches Sales in Volume by Country (2017-2028)
10.3.2 South America Transdermal Drug Patches Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Transdermal Drug Patches Sales by Type (2017-2028)
11.2 Middle East & Africa Transdermal Drug Patches Sales by Application (2017-2028)
11.3 Middle East & Africa Transdermal Drug Patches Market Size by Country
11.3.1 Middle East & Africa Transdermal Drug Patches Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Transdermal Drug Patches Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Transdermal Drug Patches and Key Manufacturers
12.2 Manufacturing Costs Percentage of Transdermal Drug Patches
12.3 Transdermal Drug Patches Production Process
12.4 Transdermal Drug Patches Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Transdermal Drug Patches Typical Distributors
13.3 Transdermal Drug Patches Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Transdermal Drug Patches Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Transdermal Drug Patches Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Hisamitsu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Hisamitsu Pharmaceutical Major Business
Table 5. Hisamitsu Pharmaceutical Transdermal Drug Patches Product and Services
Table 6. Hisamitsu Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 8. Johnson & Johnson Major Business
Table 9. Johnson & Johnson Transdermal Drug Patches Product and Services
Table 10. Johnson & Johnson Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Transdermal Drug Patches Product and Services
Table 14. Novartis Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. UCB Pharma Basic Information, Manufacturing Base and Competitors
Table 16. UCB Pharma Major Business
Table 17. UCB Pharma Transdermal Drug Patches Product and Services
Table 18. UCB Pharma Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Major Business
Table 21. Mylan Transdermal Drug Patches Product and Services
Table 22. Mylan Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Teva Pharmaceutical Major Business
Table 25. Teva Pharmaceutical Transdermal Drug Patches Product and Services
Table 26. Teva Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Nitto Denko Basic Information, Manufacturing Base and Competitors
Table 28. Nitto Denko Major Business
Table 29. Nitto Denko Transdermal Drug Patches Product and Services
Table 30. Nitto Denko Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Grünenthal Basic Information, Manufacturing Base and Competitors
Table 32. Grünenthal Major Business
Table 33. Grünenthal Transdermal Drug Patches Product and Services
Table 34. Grünenthal Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 36. IBSA Group Major Business
Table 37. IBSA Group Transdermal Drug Patches Product and Services
Table 38. IBSA Group Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. GSK Basic Information, Manufacturing Base and Competitors
Table 40. GSK Major Business
Table 41. GSK Transdermal Drug Patches Product and Services
Table 42. GSK Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 44. Luye Pharma Group Major Business
Table 45. Luye Pharma Group Transdermal Drug Patches Product and Services
Table 46. Luye Pharma Group Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Pfizer Basic Information, Manufacturing Base and Competitors
Table 48. Pfizer Major Business
Table 49. Pfizer Transdermal Drug Patches Product and Services
Table 50. Pfizer Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Chattem Basic Information, Manufacturing Base and Competitors
Table 52. Chattem Major Business
Table 53. Chattem Transdermal Drug Patches Product and Services
Table 54. Chattem Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Dr Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors
Table 56. Dr Reddy’s Laboratories Major Business
Table 57. Dr Reddy’s Laboratories Transdermal Drug Patches Product and Services
Table 58. Dr Reddy’s Laboratories Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Bayer Basic Information, Manufacturing Base and Competitors
Table 60. Bayer Major Business
Table 61. Bayer Transdermal Drug Patches Product and Services
Table 62. Bayer Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Mundipharma Basic Information, Manufacturing Base and Competitors
Table 64. Mundipharma Major Business
Table 65. Mundipharma Transdermal Drug Patches Product and Services
Table 66. Mundipharma Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Endo International Basic Information, Manufacturing Base and Competitors
Table 68. Endo International Major Business
Table 69. Endo International Transdermal Drug Patches Product and Services
Table 70. Endo International Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Beijing Tide Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Beijing Tide Pharmaceutical Major Business
Table 73. Beijing Tide Pharmaceutical Transdermal Drug Patches Product and Services
Table 74. Beijing Tide Pharmaceutical Transdermal Drug Patches Sales (M Pcs), Price (US$/Pc), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Global Transdermal Drug Patches Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Pcs)
Table 76. Global Transdermal Drug Patches Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 77. Market Position of Manufacturers in Transdermal Drug Patches, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 78. Global Transdermal Drug Patches Production Capacity by Company, (M Pcs): 2020 VS 2021
Table 79. Head Office and Transdermal Drug Patches Production Site of Key Manufacturer
Table 80. Transdermal Drug Patches New Entrant and Capacity Expansion Plans
Table 81. Transdermal Drug Patches Mergers & Acquisitions in the Past Five Years
Table 82. Global Transdermal Drug Patches Sales by Region (2017-2022) & (M Pcs)
Table 83. Global Transdermal Drug Patches Sales by Region (2023-2028) & (M Pcs)
Table 84. Global Transdermal Drug Patches Revenue by Region (2017-2022) & (USD Million)
Table 85. Global Transdermal Drug Patches Revenue by Region (2023-2028) & (USD Million)
Table 86. Global Transdermal Drug Patches Sales by Type (2017-2022) & (M Pcs)
Table 87. Global Transdermal Drug Patches Sales by Type (2023-2028) & (M Pcs)
Table 88. Global Transdermal Drug Patches Revenue by Type (2017-2022) & (USD Million)
Table 89. Global Transdermal Drug Patches Revenue by Type (2023-2028) & (USD Million)
Table 90. Global Transdermal Drug Patches Price by Type (2017-2022) & (US$/Pc)
Table 91. Global Transdermal Drug Patches Price by Type (2023-2028) & (US$/Pc)
Table 92. Global Transdermal Drug Patches Sales by Application (2017-2022) & (M Pcs)
Table 93. Global Transdermal Drug Patches Sales by Application (2023-2028) & (M Pcs)
Table 94. Global Transdermal Drug Patches Revenue by Application (2017-2022) & (USD Million)
Table 95. Global Transdermal Drug Patches Revenue by Application (2023-2028) & (USD Million)
Table 96. Global Transdermal Drug Patches Price by Application (2017-2022) & (US$/Pc)
Table 97. Global Transdermal Drug Patches Price by Application (2023-2028) & (US$/Pc)
Table 98. North America Transdermal Drug Patches Sales by Country (2017-2022) & (M Pcs)
Table 99. North America Transdermal Drug Patches Sales by Country (2023-2028) & (M Pcs)
Table 100. North America Transdermal Drug Patches Revenue by Country (2017-2022) & (USD Million)
Table 101. North America Transdermal Drug Patches Revenue by Country (2023-2028) & (USD Million)
Table 102. North America Transdermal Drug Patches Sales by Type (2017-2022) & (M Pcs)
Table 103. North America Transdermal Drug Patches Sales by Type (2023-2028) & (M Pcs)
Table 104. North America Transdermal Drug Patches Sales by Application (2017-2022) & (M Pcs)
Table 105. North America Transdermal Drug Patches Sales by Application (2023-2028) & (M Pcs)
Table 106. Europe Transdermal Drug Patches Sales by Country (2017-2022) & (M Pcs)
Table 107. Europe Transdermal Drug Patches Sales by Country (2023-2028) & (M Pcs)
Table 108. Europe Transdermal Drug Patches Revenue by Country (2017-2022) & (USD Million)
Table 109. Europe Transdermal Drug Patches Revenue by Country (2023-2028) & (USD Million)
Table 110. Europe Transdermal Drug Patches Sales by Type (2017-2022) & (M Pcs)
Table 111. Europe Transdermal Drug Patches Sales by Type (2023-2028) & (M Pcs)
Table 112. Europe Transdermal Drug Patches Sales by Application (2017-2022) & (M Pcs)
Table 113. Europe Transdermal Drug Patches Sales by Application (2023-2028) & (M Pcs)
Table 114. Asia-Pacific Transdermal Drug Patches Sales by Region (2017-2022) & (M Pcs)
Table 115. Asia-Pacific Transdermal Drug Patches Sales by Region (2023-2028) & (M Pcs)
Table 116. Asia-Pacific Transdermal Drug Patches Revenue by Region (2017-2022) & (USD Million)
Table 117. Asia-Pacific Transdermal Drug Patches Revenue by Region (2023-2028) & (USD Million)
Table 118. Asia-Pacific Transdermal Drug Patches Sales by Type (2017-2022) & (M Pcs)
Table 119. Asia-Pacific Transdermal Drug Patches Sales by Type (2023-2028) & (M Pcs)
Table 120. Asia-Pacific Transdermal Drug Patches Sales by Application (2017-2022) & (M Pcs)
Table 121. Asia-Pacific Transdermal Drug Patches Sales by Application (2023-2028) & (M Pcs)
Table 122. South America Transdermal Drug Patches Sales by Country (2017-2022) & (M Pcs)
Table 123. South America Transdermal Drug Patches Sales by Country (2023-2028) & (M Pcs)
Table 124. South America Transdermal Drug Patches Revenue by Country (2017-2022) & (USD Million)
Table 125. South America Transdermal Drug Patches Revenue by Country (2023-2028) & (USD Million)
Table 126. South America Transdermal Drug Patches Sales by Type (2017-2022) & (M Pcs)
Table 127. South America Transdermal Drug Patches Sales by Type (2023-2028) & (M Pcs)
Table 128. South America Transdermal Drug Patches Sales by Application (2017-2022) & (M Pcs)
Table 129. South America Transdermal Drug Patches Sales by Application (2023-2028) & (M Pcs)
Table 130. Middle East & Africa Transdermal Drug Patches Sales by Region (2017-2022) & (M Pcs)
Table 131. Middle East & Africa Transdermal Drug Patches Sales by Region (2023-2028) & (M Pcs)
Table 132. Middle East & Africa Transdermal Drug Patches Revenue by Region (2017-2022) & (USD Million)
Table 133. Middle East & Africa Transdermal Drug Patches Revenue by Region (2023-2028) & (USD Million)
Table 134. Middle East & Africa Transdermal Drug Patches Sales by Type (2017-2022) & (M Pcs)
Table 135. Middle East & Africa Transdermal Drug Patches Sales by Type (2023-2028) & (M Pcs)
Table 136. Middle East & Africa Transdermal Drug Patches Sales by Application (2017-2022) & (M Pcs)
Table 137. Middle East & Africa Transdermal Drug Patches Sales by Application (2023-2028) & (M Pcs)
Table 138. Transdermal Drug Patches Raw Material
Table 139. Key Manufacturers of Transdermal Drug Patches Raw Materials
Table 140. Direct Channel Pros & Cons
Table 141. Indirect Channel Pros & Cons
Table 142. Transdermal Drug Patches Typical Distributors
Table 143. Transdermal Drug Patches Typical Customers
List of Figures
Figure 1. Transdermal Drug Patches Picture
Figure 2. Global Transdermal Drug Patches Revenue Market Share by Type in 2021
Figure 3. Methyl Salicylate-based Patch
Figure 4. Rivastigmine Transdermal Patch
Figure 5. Fentanyl Transdermal Patch
Figure 6. Lidocaine Patch
Figure 7. Diclofenac Patch
Figure 8. Nicotine Transdermal Patch
Figure 9. Others
Figure 10. Global Transdermal Drug Patches Revenue Market Share by Application in 2021
Figure 11. Rx Channel
Figure 12. OTC Channel
Figure 13. Global Transdermal Drug Patches Revenue, (USD Million) & (M Pcs): 2017 & 2021 & 2028
Figure 14. Global Transdermal Drug Patches Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Transdermal Drug Patches Sales (2017-2028) & (M Pcs)
Figure 16. Global Transdermal Drug Patches Price (2017-2028) & (US$/Pc)
Figure 17. Global Transdermal Drug Patches Production Capacity (2017-2028) & (M Pcs)
Figure 18. Global Transdermal Drug Patches Production Capacity by Geographic Region: 2022 VS 2028
Figure 19. Transdermal Drug Patches Market Drivers
Figure 20. Transdermal Drug Patches Market Restraints
Figure 21. Transdermal Drug Patches Market Trends
Figure 22. Global Transdermal Drug Patches Sales Market Share by Manufacturer in 2021
Figure 23. Global Transdermal Drug Patches Revenue Market Share by Manufacturer in 2021
Figure 24. Transdermal Drug Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 25. Top 3 Transdermal Drug Patches Manufacturer (Revenue) Market Share in 2021
Figure 26. Top 6 Transdermal Drug Patches Manufacturer (Revenue) Market Share in 2021
Figure 27. Global Transdermal Drug Patches Sales Market Share by Region (2017-2028)
Figure 28. Global Transdermal Drug Patches Revenue Market Share by Region (2017-2028)
Figure 29. North America Transdermal Drug Patches Revenue (2017-2028) & (USD Million)
Figure 30. Europe Transdermal Drug Patches Revenue (2017-2028) & (USD Million)
Figure 31. Asia-Pacific Transdermal Drug Patches Revenue (2017-2028) & (USD Million)
Figure 32. South America Transdermal Drug Patches Revenue (2017-2028) & (USD Million)
Figure 33. Middle East & Africa Transdermal Drug Patches Revenue (2017-2028) & (USD Million)
Figure 34. Global Transdermal Drug Patches Sales Market Share by Type (2017-2028)
Figure 35. Global Transdermal Drug Patches Revenue Market Share by Type (2017-2028)
Figure 36. Global Transdermal Drug Patches Price by Type (2017-2028) & (US$/Pc)
Figure 37. Global Transdermal Drug Patches Sales Market Share by Application (2017-2028)
Figure 38. Global Transdermal Drug Patches Revenue Market Share by Application (2017-2028)
Figure 39. Global Transdermal Drug Patches Price by Application (2017-2028) & (US$/Pc)
Figure 40. North America Transdermal Drug Patches Sales Market Share by Type (2017-2028)
Figure 41. North America Transdermal Drug Patches Sales Market Share by Application (2017-2028)
Figure 42. North America Transdermal Drug Patches Sales Market Share by Country (2017-2028)
Figure 43. North America Transdermal Drug Patches Revenue Market Share by Country (2017-2028)
Figure 44. United States Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Canada Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Mexico Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Europe Transdermal Drug Patches Sales Market Share by Type (2017-2028)
Figure 48. Europe Transdermal Drug Patches Sales Market Share by Application (2017-2028)
Figure 49. Europe Transdermal Drug Patches Sales Market Share by Country (2017-2028)
Figure 50. Europe Transdermal Drug Patches Revenue Market Share by Country (2017-2028)
Figure 51. Germany Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. France Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. United Kingdom Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Russia Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Italy Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Asia-Pacific Transdermal Drug Patches Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Transdermal Drug Patches Sales Market Share by Application (2017-2028)
Figure 58. Asia-Pacific Transdermal Drug Patches Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Transdermal Drug Patches Revenue Market Share by Region (2017-2028)
Figure 60. China Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Japan Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Korea Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. India Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Southeast Asia Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Australia Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South America Transdermal Drug Patches Sales Market Share by Type (2017-2028)
Figure 67. South America Transdermal Drug Patches Sales Market Share by Application (2017-2028)
Figure 68. South America Transdermal Drug Patches Sales Market Share by Country (2017-2028)
Figure 69. South America Transdermal Drug Patches Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East & Africa Transdermal Drug Patches Sales Market Share by Type (2017-2028)
Figure 73. Middle East & Africa Transdermal Drug Patches Sales Market Share by Application (2017-2028)
Figure 74. Middle East & Africa Transdermal Drug Patches Sales Market Share by Region (2017-2028)
Figure 75. Middle East & Africa Transdermal Drug Patches Revenue Market Share by Region (2017-2028)
Figure 76. Turkey Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Egypt Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Saudi Arabia Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. South Africa Transdermal Drug Patches Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Manufacturing Cost Structure Analysis of Transdermal Drug Patches in 2021
Figure 81. Manufacturing Process Analysis of Transdermal Drug Patches
Figure 82. Transdermal Drug Patches Industrial Chain
Figure 83. Sales Channel: Direct Channel vs Indirect Channel
Figure 84. Methodology
Figure 85. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
